| Literature DB >> 24405608 |
Donna Brassil1, Rhonda G Kost, Kathleen A Dowd, Arlene M Hurley, Tyler-Lauren Rainer, Barry S Coller.
Abstract
The development of translational clinical research protocols is complex. To assist investigators, we developed a structured supportive guidance process (Navigation) to expedite protocol development to the standards of good clinical practice (GCP), focusing on research ethics and integrity. Navigation consists of experienced research coordinators leading investigators through a concerted multistep protocol development process from concept initiation to submission of the final protocol. To assess the effectiveness of Navigation, we collect data on the experience of investigators, the intensity of support required for protocol development, IRB review outcomes, and protocol start and completion dates. One hundred forty-four protocols underwent Navigation and achieved IRB approval since the program began in 2007, including 37 led by trainee investigators, 26 led by MDs, 9 by MD/PhDs, 57 by PhDs, and 12 by investigators with other credentials (e.g., RN, MPH). In every year, more than 50% of Navigated protocols were approved by the IRB within 30 days. For trainees who had more than one protocol navigated, the intensity of Navigation support required decreased over time. Navigation can increase access to translational studies for basic scientists, facilitate GCP training for investigators, and accelerate development and approval of protocols of high ethical and scientific quality.Entities:
Keywords: FDA; translational research; trials
Mesh:
Year: 2014 PMID: 24405608 PMCID: PMC4074027 DOI: 10.1111/cts.12134
Source DB: PubMed Journal: Clin Transl Sci ISSN: 1752-8054 Impact factor: 4.689